Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Relay Therapeutics, Inc. (RLAY) had Weighted-Average Shares Outstanding (Diluted) of 171.26M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$0.68M |
|
$-70.38M |
|
-- |
|
$0.68M |
|
$77.52M |
|
$-76.85M |
|
$6.47M |
|
$-70.38M |
|
$-70.38M |
|
$-70.38M |
|
$-70.38M |
|
$-70.38M |
|
$-70.38M |
|
$-76.85M |
|
$-74.94M |
|
171.26M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
171.26M |
$-0.41 |
|
$-0.41 |
|
| Balance Sheet Financials | |
$680.39M |
|
$3.46M |
|
$48.45M |
|
$728.84M |
|
$32.52M |
|
-- |
|
$30.66M |
|
$63.18M |
|
$665.66M |
|
$665.66M |
|
$665.66M |
|
171.69M |
|
| Cash Flow Statement Financials | |
$-128.47M |
|
$117.61M |
|
$0.65M |
|
$126.41M |
|
$116.20M |
|
$-10.21M |
|
$33.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-11351.11% |
|
-11351.11% |
|
-- |
|
-10395.13% |
|
-10395.13% |
|
$-128.88M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-10.57% |
|
-10.57% |
|
-9.66% |
|
-10.57% |
|
$3.88 |
|
$-0.75 |
|
$-0.75 |
|